in: Year-book of non invasive ventilation in Sleep and Pulmonary Critical Care, Antonio Esquinass, Editor, NOVA Science Publishers Inc. , New-York, pp.111-120, 2020
Obstructve sleep apnea (OSA) s a syndrome wth repeated obstructon of the upper arway whch results n cessaton of arflow, wth dsturbance n saturaton followed by arousals from sleep. Loud snorng and wtnessed apnea are the cardnal symptoms of OSA, but these symptoms cannot be self-reported. OSA can be assocated wth mpared qualty of lfe, depressve mood, and excessve daytme sleepness. Postve arway pressure (PAP) s the frst-lne opton n treatment of obstructve sleep apnea. For effectve outcomes, PAP treatment should be at least 4 h per nght. Excessve daytme sleepness, mpared qualty of lfe, and depressve mood are expected to be healed wth CPAP treatment n OSA. Most of the researches reported that wth an effectve PAP complance, daytme symptoms, qualty of lfe, and depressve mood can be mproved; however there also studes that addressed no postve effect of CPAP therapy on these clncal outcomes. In ths chapter the assocaton of OSA wth mpared qualty of lfe, depresson, and excessve daytme sleepness wll be evaluated; moreover, mpact of CPAP treatment on these self-reported outcomes wll be dscussed.